Hsp90 plays a significant role in multidrug resistance (MDR) in cancer by positively regulating the expression of various resistance-associated proteins, including P-glycoprotein (P-gp/MDR1), breast cancer resistance protein (BCRP), survivin, and Bcl-2 [129,130]. This evidence concerns the gene HSP90AB1 and cancer.